Key Financial Data Of Group

Daito Pharmaceutical Co., Ltd. - Filing #7569991

Concept As at
2023-02-28
2022-12-01 to
2023-02-28
2022-06-01 to
2023-02-28
2021-06-01 to
2022-05-31
As at
2022-05-31
2021-12-01 to
2022-02-28
2021-06-01 to
2022-02-28
As at
2022-02-28
Key financial data of group
Business results of group
Net sales
34,570,000,000 JPY
43,464,000,000 JPY
33,583,000,000 JPY
Ordinary profit (loss)
4,077,000,000 JPY
6,729,000,000 JPY
5,794,000,000 JPY
Profit (loss) attributable to owners of parent
2,660,000,000 JPY
4,668,000,000 JPY
3,978,000,000 JPY
Comprehensive income
2,918,000,000 JPY
4,821,000,000 JPY
4,069,000,000 JPY
Net assets
49,851,000,000 JPY
47,674,000,000 JPY
46,304,000,000 JPY
Total assets
68,602,000,000 JPY
64,939,000,000 JPY
62,679,000,000 JPY
Basic earnings (loss) per share
62.52
184.98
335.41
85.76
287.81
Diluted earnings per share
184.76
Equity-to-asset ratio
0.722 xbrli:pure
0.728 xbrli:pure
0.733 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.